# A New Approach to Target the Substrates of Persistent Atrial Fibrillation: The Sequential Substrate Ablation Approach

Study · id `cardio:ct-nct02654353` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02654353](<https://clinicaltrials.gov/study/NCT02654353>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02654353

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

## Technical summary

Registry record NCT02654353. Randomized; no masking; primary purpose treatment. Start 2012-02 (registry gives no type); primary completion 2015-12 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 100 participants (enrolled count; ClinicalTrials.gov record NCT02654353, source copy `cardio:ctgov-nct02654353-2016-01-13`, retrieved 2026-10-26)
- Start date: 2012-02 (registry gives no type) (ClinicalTrials.gov record NCT02654353, source copy `cardio:ctgov-nct02654353-2016-01-13`, retrieved 2026-10-26)
- Primary completion: 2015-12 (actual) (ClinicalTrials.gov record NCT02654353, source copy `cardio:ctgov-nct02654353-2016-01-13`, retrieved 2026-10-26)
- Completion: 2015-12 (actual) (ClinicalTrials.gov record NCT02654353, source copy `cardio:ctgov-nct02654353-2016-01-13`, retrieved 2026-10-26)
- Countries: Germany (ClinicalTrials.gov record NCT02654353, source copy `cardio:ctgov-nct02654353-2016-01-13`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02654353-2016-01-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: A New Approach to Target the Substrates of Persistent Atrial Fibrillation: The Sequential Substrate Ablation Approach
- Condition: Persistent Atrial Fibrillation
- Intervention (Procedure): Ablation
- Lead sponsor: Johannes Gutenberg University Mainz
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Johannes Gutenberg University Mainz (`cardio:org-johannes-gutenberg-university-mainz`)

## Provenance

Content hash: f0a4c1555fc36a39e2a942d598b6fb9981b636e782d51fab59bbcfc2e4d1abe5
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
